This content is machine translated Cimicifuga racemosa Phytotherapy versus hormone replacement therapy Cimicifuga racemosa is a herbal medicine commonly used in clinical practice in peri- and postmenopausal women. Like hormone replacement therapy, it is used in menopausal syndrome. Christine Bodmer, MD, of…
View Post 4 min This content is machine translated Gastric Cancer Targeted therapies in HER2-positive tumors. To what extent does the biological understanding of the disease help define the therapy? This question was discussed at the ASCO-GI in San Francisco with regard to potential treatment options…
View Post 3 min This content is machine translated Gynecological topics in practice From menstrual cramps to medications in pregnancy The annual symposium for general practitioners and gynecologists was held in Olten at the end of January. HAUSARZT PRAXIS was on site and reports on the one hand about the…
View Post 4 min This content is machine translated Lymphomas What the family doctor needs to know At the SGIM Great Update in Interlaken, the most common problems and challenges that a family physician encounters when dealing with patients suffering from lymphoma were discussed. The only difficulty…
View Post 4 min This content is machine translated Chronic rhinosinusitis Colorful mixture instead of independent disease? If a patient suffers from chronic inflammation of the mucous membranes in the nose and sinuses, it is important to look closely. Especially the polypous variant could be associated with…
View Post 4 min This content is machine translated Lung, kidney cancer and chronic myeloid leukemia What does modern clinical practice look like? At the DGHO Congress in Vienna, various aspects in clinical practice in non-small cell lung cancer (NSCLC), renal cell cancer (RCC) and chronic myeloid leukemia were addressed. In particular, the…
View Post 2 min This content is machine translated Stage 2 analysis of the CLL11 study Is the chlorambucil combination with GA101 superior to that with rituximab? At the ASH Congress in New Orleans, one of the topics was the CLL11 Phase 3 trial. After showing in the last issue of InFo ONCOLOGY & HEMATOLOGY that the…
View Post 3 min This content is machine translated Non-Hodgkin's Lymphoma Pomalidomide in high-risk patients. Because data on the efficacy of pomalidomide in high-risk relapsed/refractory multiple myeloma populations are sparse, a phase II study set out to evaluate the agent in patients with GEP70 or…
View Post 3 min This content is machine translated Follicular lymphoma Rituximab in maintenance monotherapy. A study presented at ASH 2013 in New Orleans examined the role of rituximab in maintenance therapy in patients with follicular lymphoma. The study showed that the drug, when applied…
View Post 3 min This content is machine translated Newly diagnosed multiple myeloma Does a proteasome inhibitor offer new therapeutic options? One study discussed at the ASH meeting involved a regimen consisting of oral MLN9708 administered twice weekly plus lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma. It concludes…
View Post 2 min This content is machine translated Multiple Myeloma Media Workshop Which form of therapy is suitable for whom? At a media workshop during the ASH Congress in New Orleans, some key points of myeloma research were presented. They also discussed what these innovations mean for patients and used…
